Bladder cancer diagnostics specialist Pacific Edge has reported a drop in testing volumes in the three months to December, an outcome it attributes to a smaller sales team after cutting costs to preserve cash.
In a statement to the NZX, Pacific Edge said it processed 7172 tests for its Cxbladder
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
